ATAI Life Sciences AG

IntelGenx and its subsidiary IGX received approval from the Superior Court of Québec for a reorganization involving the incorporation of two new entities, Residual IGX and New ParentCo, and the exchange of IGX shares for New ParentCo shares. atai Life Sciences AG acquired all IGX shares through a credit bid, with no equity or cash exchanged. Shareholders will not receive payments or distributions, and the remaining entities are expected to file for bankruptcy.